|
|
Article: PharmaNetics Receives $1.5 Million Payment From AstraZeneca.
- Article from:
- Business Wire
- Article date:
- July 26, 2001
CopyrightCOPYRIGHT 2001 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors & Health/Medical Writers
RALEIGH, N.C.--(BW HealthWire)--July 26, 2001
PharmaNetics, Inc. (Nasdaq/NM: PHAR), a leading company specializing in theranostic management of various therapeutics affecting coagulation, announced today that it had received a $1.5 million payment from AstraZeneca (AZ), payable in connection with its December 1999 AZ Interim Agreement. The payment is required under circumstances where AZ does not enter into a Collaboration and Supply Agreement with PharmaNetics by March 31, 2001. In communicating with PharmaNetics, AZ has indicated that ongoing clinical studies of its oral thrombin inhibitor, H 376/95, ...